Kristan Meetze
2PUBLICATIONS
8CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Jun 06, 2024
CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity.Naveen K Mehta, Kavya Rakhra, Kristan A Meetze
|Aug 16, 2023
CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression.Kristan Meetze, Naveen K Mehta, Bochong Li
Pageof 1

